Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Effects of PRP, PPP, and BMAC on recovery after hip surgery for labral issues

Official title: Effect of Platelet-Rich Plasma, Platelet-Poor Plasma, & Bone Marrow Aspirate Concentrate Application on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies: A Prospective Randomized Controlled Trial

Run by Massachusetts General Hospital · NCT06003101 · Data updated 2026-11-12

This study is testing whether treatments like platelet-rich plasma and bone marrow concentrate can help people recover better after hip surgery for labral issues.

More Chondral Defect trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedAugust 30, 2023
Main results expectedAugust 30, 2027
Study endsAugust 30, 2045
Registry record updatedNovember 20, 2024
Trial IDNCT06003101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who require hip arthroscopy for labral pathology.

Probably not a fit

Patients who have had prior surgeries on the same hip or are non-English speakers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the impact of platelet-rich plasma (PRP), platelet-poor plasma (PPP), and bone marrow aspirate concentrate (BMAC) on functional recovery following hip arthroscopy for acetabular labral pathologies. The study aims to determine whether these treatments can enhance functional outcomes and reduce arthritic symptoms post-surgery. Participants will be randomly assigned to receive either the treatment or a control, with outcomes measured through validated functional assessments. The trial is designed to provide insights into optimizing surgical management of labral injuries.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery and reduced pain for patients undergoing hip arthroscopy for labral pathologies.

How similar studies have gone: Previous studies have shown promising results with similar regenerative approaches, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: \> or equal to 18 years
* Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
* Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document

Exclusion Criteria:

* Non-English speaking (PROM surveys are only validated in English)
* Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.